Cited by 2,337Pancreatic and Hepatic Oncology ResearchGenetic factors in colorectal cancerCancer-related Molecular Pathways

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

DPC4 , A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1

Hahn, Stephan A., Schutte, Mieke, Shamsul Hoque, A. T. M., Moskaluk, Christopher A., da Costa, Luis T., Rozenblum, Ester, Weinstein, Craig L., Fischer, Aryeh, Yeo, Charles J., Hruban, Ralph H., Kern, Scott E.·1996·Science

DOI 10.1126/science.271.5247.350

Open this paper in CoChat — free account

Abstract

About 90 percent of human pancreatic carcinomas show allelic loss at chromosome 18q. To identify candidate tumor suppressor genes on 18q, a panel of pancreatic carcinomas were analyzed for convergent sites of homozygous deletion. Twenty-five of 84 tumors had homozygous deletions at 18q21.1, a site that excludes DCC (a candidate suppressor gene for colorectal cancer) and includes DPC4 , a gene similar in sequence to a Drosophila melanogaster gene ( Mad ) implicated in a transforming growth factor-β (TGF-β)-like signaling pathway. Potentially inactivating mutations in DPC4 were identified in six of 27 pancreatic carcinomas that did not have homozygous deletions at 18q21.1. These results identify DPC4 as a candidate tumor suppressor gene whose inactivation may play a role in pancreatic and possibly other human cancers.

Integrity signals

Registry

Crossref · 10.1126/science.271.5247.350

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

A cell cycle regulator potentially involved in genesis of many tumor types
Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., Johnson, B. E., & Skolnick, M. H. (1994) · Science · doi:10.1126/science.8153634 · Cited by 2,751
Inactivation of the Type II TGF-β Receptor in Colon Cancer Cells with Microsatellite Instability
Markowitz, S. D., Wang, J., Myeroff, L. L., Parsons, R. E., Sun, L., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W., Vogelstein, B., et al. (1995) · Science · doi:10.1126/science.7761852 · Cited by 2,267
Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes
Almoguera, C., Shibata, D. K., Forrester, K., Wj, M., Arnheim, N., & Perucho, M. (1988) · Cell · doi:10.1016/0092-8674(88)90571-5 · Cited by 2,122
pl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrest
Hannon, G. J., & Beach, D. (1994) · Nature · doi:10.1038/371257a0 · Cited by 1,950
Tumor Suppressor Genes
Weinberg, R. A. (1991) · Science · doi:10.1126/science.1659741 · Cited by 1,765
Identification of a Chromosome 18q Gene that Is Altered in Colorectal Cancers
Fearon, E. R., Cho, K. R., Nigro, J. M., Kern, S. E., Simons, J. W., Ruppert, J. M., Hamilton, S. R., Preisinger, A. C., Thomas, G., Kinzler, K. W., et al. (1990) · Science · doi:10.1126/science.2294591 · Cited by 1,760
Self-citation
The Molecular Genetics of Cancer
Bishop, J. M. (1987) · Science · doi:10.1126/science.3541204 · Cited by 1,674
Hereditary cancer, oncogenes, and antioncogenes.
Knudson, A. G. (1985) · PubMed · Cited by 1,218
Thermal asymmetric interlaced PCR: automatable amplification and sequencing of insert end fragments from P1 and YAC clones for chromosome walking
Liu, Y., & Whittier, R. F. (1995) · Genomics · doi:10.1016/0888-7543(95)80010-j · Cited by 1,141
Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma
Caldas, C., Hahn, S. A., da Costa, L. T., Redston, M. S., Schutte, M. E. M., Seymour, A. B., Weinstein, C. L., Hruban, R. H., Yeo, C. J., & Kern, S. E. (1994) · Nature Genetics · doi:10.1038/ng0994-27 · Cited by 1,132
Self-citation

Flagged first, then by citations

Show all 25 references

Research works printed but not linked: 2

HAHN A. S., IN PRESS CANCER RES .
LEACH S. F., COMMUNICATION .

Sorted by citations

Items 401–500 of 1,002

Specificity of TGFβ signaling is conferred by distinct type I receptors and their associated SMAD proteins in Caenorhabditis elegans
Krishna, S., Maduzia, L. L., & Padgett, R. W. (1999) · Development · doi:10.1242/dev.126.2.251 · Cited by 136
Suppression of matrix metalloproteinase-9 transcription by transforming growth factor-β is mediated by a nuclear factor-κB site
OGAWA, K., CHEN, F., KUANG, C., & CHEN, Y. (2004) · Biochemical Journal · doi:10.1042/bj20040058 · Cited by 116
Genetic Mutations Associated with Cigarette Smoking in Pancreatic Cancer
Blackford, A. L., Parmigiani, G., Kensler, T. W., Wolfgang, C. L., Jones, S., Zhang, X., Parsons, D. W., Lin, J., Leary, R. J., Eshleman, J. R., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0015 · Cited by 134
Self-citation
Molecular Mechanisms of Transforming Growth Factor- Signaling
Hu, P. P.-C., Datto, M., & Wang, X. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.3.0333 · Cited by 137
Intraductal papillary mucinous neoplasm
Shi, C., & Hruban, R. H. (2011) · Human Pathology · doi:10.1016/j.humpath.2011.04.003 · Cited by 133
Self-citation
Fine Tuning and Cross-talking of TGF-β Signal by Inhibitory Smads
Park, S. H. (2005) · BMB Reports · doi:10.5483/bmbrep.2005.38.1.009 · Cited by 133
The Role of NLRP3 Inflammasome Activation in the Epithelial to Mesenchymal Transition Process During the Fibrosis
Alyaseer, A. A. A., de Lima, M. H. S., & Braga, T. T. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00883 · Cited by 135
Gene deregulation in gastric cancer
Stock, M., & Otto, F. (2005) · Gene · doi:10.1016/j.gene.2005.06.026 · Cited by 133
Immunohistochemical evaluation of K-ras, p53, and HER-2/neu expression in hyperplastic, dysplastic, and carcinomatous lesions of the pancreas: Evidence for multistep carcinogenesis
Apple, S. K., Hecht, J. R., Lewin, D., Jahromi, S. A., Grody, W. W., & Nieberg, R. K. (1999) · Human Pathology · doi:10.1016/s0046-8177(99)90265-4 · Cited by 133
Bone morphogenetic protein-5, -6 and -7 inhibit growth and induce apoptosis in human myeloma cells
Rø, T. B., Holt, R. U., Brenne, A., Hjorth‐Hansen, H., Waage, A., Hjertner, Ø., Sundan, A., & Børset, M. (2003) · Oncogene · doi:10.1038/sj.onc.1207386 · Cited by 132
Pancreatic Cancer
Kleeff, J. H., Michalski, C. W., Frieß, H., & Büchler, M. W. (2006) · Pancreas · doi:10.1097/01.mpa.0000229010.62538.f2 · Cited by 132
TGFβ inducible early gene enhances TGFβ/Smad-dependent transcriptional responses
Johnsen, S. A., Subramaniam, M., Janknecht, R., & Spelsberg, T. C. (2002) · Oncogene · doi:10.1038/sj.onc.1205681 · Cited by 132
Loss of the Smad3 expression increases susceptibility to tumorigenicity in human gastric cancer
Han, S., Kim, H.-T., Seong, D. H., Kim, Y. S., Park, Y., Bang, Y., Yang, H., & Kim, S. (2003) · Oncogene · doi:10.1038/sj.onc.1207259 · Cited by 130
Alterations in the Smad pathway in human cancers
Samanta, D. (2011) · Frontiers in bioscience · doi:10.2741/3986 · Cited by 142
TGF-β Signaling in Bone Remodeling and Osteosarcoma Progression
Lamora, A., Talbot, J., Mullard, M., Royer, B. B.-L., Rédiní, F., & Verrecchia, F. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5110096 · Cited by 141
The proteasome inhibitor bortezomib enhances the activity of docetaxel in orthotopic human pancreatic tumor xenografts
Nawrocki, S. T., Sweeney‐Gotsch, B., Takamori, R. K., & McConkey, D. J. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.59.3.1 · Cited by 131
Upregulation of two BH3-only proteins, Bmf and Bim, during TGFβ-induced apoptosis
Ramjaun, A. R., Tomlinson, S., Eddaoudi, A., & Downward, J. (2006) · Oncogene · doi:10.1038/sj.onc.1209852 · Cited by 131
Immunohistochemical analysis of Bcl-2 family proteins in adenocarcinomas of the stomach.
Krajewska, M., Fenoglio‐Preiser, C. M., Krajewski, S., Song, K. B., Macdonald, J. S., Stemmerman, G., & Reed, J. C. (1996) · Europe PMC (PubMed Central) · Cited by 131
Prognostic significance of allelic loss at chromosome 18q21 for stage II colorectal cancer
Carethers, J. M., Hawn, M. T., Greenson, J. K., Hitchcock, C. L., & Boland, C. R. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70424-x · Cited by 131
Biomarkers of TGF-β Signaling Pathway and Prognosis of Pancreatic Cancer
Javle, M. M., Li, Y., Tan, D., Dong, X., Chang, P., Kar, S., & Li, D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085942 · Cited by 131
TGF-β signaling in cell fate control and cancer
Yu, Y., & Feng, X. (2019) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2019.07.007 · Cited by 130
Identification of 27 5′ CpG islands aberrantly methylated and 13 genes silenced in human pancreatic cancers
Hagihara, A., Miyamoto, K., Furuta, J., Hiraoka, N., Wakazono, K., Seki, S., Fukushima, S., Tsao, M., Sügimura, T., & Ushijima, T. (2004) · Oncogene · doi:10.1038/sj.onc.1207783 · Cited by 130
Frequent loss of SMAD4/DPC4 protein in colorectal cancers
Salovaara, R., Roth, S., Loukola, A., Launonen, V., Sistonen, P., Avizienyte, E., Kristo, P., Järvinen, H., Souchelnytskyi, S., Sarlomo‐Rikala, M., et al. (2002) · Gut · doi:10.1136/gut.51.1.56 · Cited by 133
Mutations of the DPC4/Smad4 gene in neuroendocrine pancreatic tumors
Bartsch, D. K., Hahn, S. A., Danichevski, K. D., Ramaswamy, A., Bastian, D., Galehdari, H., Barth, P. J., Schmiegel, W., Simon, B., & Rothmund, Μ. (1999) · Oncogene · doi:10.1038/sj.onc.1202585 · Cited by 130
Self-citation
Developmental Genes and Cancer: Role of Patched in Basal Cell Carcinoma of the Skin
Gailani, M. R., & Bale, A. E. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.15.1103 · Cited by 130
Cdk4/6 Inhibition Induces Epithelial–Mesenchymal Transition and Enhances Invasiveness in Pancreatic Cancer Cells
Liu, F., & Korc, M. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0562 · Cited by 132
Distinct progression pathways involving the dysfunction of DUSP6/MKP-3 in pancreatic intraepithelial neoplasia and intraductal papillary-mucinous neoplasms of the pancreas
Furukawa, T., Fujisaki, R., Yoshida, Y., Kanai, N., Sunamura, M., Abe, T., Takeda, K., Matsuno, S., & Horii, A. (2005) · Modern Pathology · doi:10.1038/modpathol.3800383 · Cited by 128
High-Resolution Genomic and Expression Profiling Reveals 105 Putative Amplification Target Genes in Pancreatic Cancer
Mahlamäki, E., Kauraniemi, P., Monni, O. M., Wolf, M., Hautaniemi, S., & Kallioniemi, A. H. (2004) · Neoplasia · doi:10.1593/neo.04130 · Cited by 128
Frequent homozygous deletion of the LKB1/STK11 gene in non-small cell lung cancer
Gill, R. K., Yang, S.-H., Meerzaman, D. M., Mechanic, L. E., Bowman, E. D., Jeon, H.-S., Roy‐Chowdhuri, S., Shakoori, A., Dracheva, T., Hong, K.-M., et al. (2011) · Oncogene · doi:10.1038/onc.2011.98 · Cited by 125
A Deletion in the Gene for Transforming Growth Factor β Type I Receptor Abolishes Growth Regulation by Transforming Growth Factor β in a Cutaneous T-Cell Lymphoma
Schiemann, W. P., Pfeifer, W. M., Levi, E., Kadin, M. E., & Lodish, H. F. (1999) · Blood · doi:10.1182/blood.v94.8.2854.420k07_2854_2861 · Cited by 127
Cancer associated fibroblasts stimulated by transforming growth factor beta1 (TGF-β1) increase invasion rate of tumor cells: a population study
Casey, T. M., Eneman, J., Crocker, A., White, J., Tessitore, J., Stanley, M., Harlow, S., Bunn, J. Y., Weaver, D., Muss, H., et al. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9684-7 · Cited by 127
Analysis of Drosophila Segmentation Network Identifies a JNK Pathway Factor Overexpressed in Kidney Cancer
Liu, J., Ghanim, M., Xue, L., Brown, C. D., Iossifov, I. H., Angeletti, C., Hua, S., Negre, N. N., Ludwig, M., Stricker, T. P., et al. (2009) · Science · doi:10.1126/science.1157669 · Cited by 125
miR-192, miR-194, miR-215, miR-200c and miR-141 are downregulated and their common target ACVR2B is strongly expressed in renal childhood neoplasms
Senanayake, U., Das, S. K., Vesely, P. W., Zoughbi, W. A., Fröhlich, L. F., Chowdhury, P., Leuschner, I., Höefler, G., & Guertl, B. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs126 · Cited by 124
Role of Radiation-induced TGF-beta Signaling in Cancer Therapy
Dancea, H. C. (2009) · Molecular and Cellular Pharmacology · doi:10.4255/mcpharmacol.09.06 · Cited by 126
Cancer of the Pancreas
Anderson, K. E., Mack, T. M., & Silverman, D. T. (2006) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195149616.003.0038 · Cited by 124
Relative expression of E-cadherin and type IV collagenase genes predicts disease outcome in patients with resectable pancreatic carcinoma.
Kuniyasu, H., Ellis, L. M., Evans, D. B., Abbruzzese, J. L., Fenoglio, C. J., Bucana, C. D., Cleary, K. R., Tahara, E., & Fidler, I. J. (1999) · PubMed · Cited by 124
Genetic progression and heterogeneity in intraductal papillary-mucinous neoplasms of the pancreas.
Fujii, H., Inagaki, M., Kasai, S., Miyokawa, N., Tokusashi, Y., Gabrielson, E., & Hruban, R. H. (1997) · Europe PMC (PubMed Central) · Cited by 124
Self-citation
An Algorithmic Immunohistochemical Approach to Define Tumor Type and Assign Site of Origin
Bellizzi, A. M. (2020) · Advances in Anatomic Pathology · doi:10.1097/pap.0000000000000256 · Cited by 131
Aggressive PDACs Show Hypomethylation of Repetitive Elements and the Execution of an Intrinsic IFN Program Linked to a Ductal Cell of Origin
Espinet, E., Gu, Z., Imbusch, C. D., Giese, N. A., Büscher, M., Safavi, M., Weisenburger, S., Klein, C., Vogel, V., Falcone, M., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1202 · Cited by 124
Genome profiling of pancreatic adenocarcinoma
Birnbaum, D. J., Adélaïde, J., Mamessier, E., Finetti, P., Lagarde, A., Monges, G., Viret, F., Gonçalvès, A., Turrini, O., Delpero, J., et al. (2011) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.20870 · Cited by 122
Genetic alterations in pancreatic carcinoma.
Schneider, G., & Schmid, R. M. (2003) · Molecular Cancer · doi:10.1186/1476-4598-2-15 · Cited by 121
Two discrete regions of deletion at 7q in uterine leiomyomas
Ishwad, C. S., Ferrell, R. E., Hanley, K., Davare, J., Meloni, A. M., Sandberg, A. A., & Surti, U. (1997) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199707)19:3 · Cited by 49
Matrix-based comparative genomic hybridization: Biochips to screen for genomic imbalances
Solinas‐Toldo, S., Lampel, S., Stilgenbauer, S., Nickolenko, J., Benner, A., Döhner, H., Cremer, T. J., & Lichter, P. (1997) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199712)20:4 · Cited by 1,002
Molecular analysis of microdissected tumors and preneoplastic intraductal lesions in pancreatic carcinoma
Heinmöller, E., Dietmaier, W., Zirngibl, H., Heinmöller, P., Scaringe, W., Jauch, K.-W., Hofstädter, F., & Rüschoff, J. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64520-8 · Cited by 121
On the existence of cytokines in invertebrates
Beschin, A., Bilej, M., Torreele, E., & BAETSELIER, P. D. (2001) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000901 · Cited by 121
Analysis of specific gene mutations in the transforming growth factor-beta signal transduction pathway in human ovarian cancer.
Wang, D., Kanuma, T., Mizunuma, H., Takama, F., Ibuki, Y., Wake, N., Mogi, A., Shitara, Y., & Takenoshita, S. (2000) · PubMed · Cited by 121
Mediation of the DCC Apoptotic Signal by DIP13α
Liu, J., Yao, F., Wu, R., Morgan, M., Thorburn, A., Finley, R. L., & Chen, Y. Q. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204679200 · Cited by 120
Prognostic and predictive markers in pancreatic adenocarcinoma
Le, N. N. H., Sund, M., Vinci, A., Beyer, G., Javed, M., Krug, S., Neessee, A., & Schober, M. (2015) · Digestive and Liver Disease · doi:10.1016/j.dld.2015.11.001 · Cited by 122
microRNA-183 is an oncogene targeting Dkk-3 and SMAD4 in prostate cancer
Ueno, K., Hirata, H., Shahryari, V., Deng, G., Tanaka, Y., Tabatabai, Z. L., Hinoda, Y., & Dahiya, R. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.125 · Cited by 119
The molecular and cellular heterogeneity of pancreatic ductal adenocarcinoma
Samuel, N., & Hudson, T. J. (2011) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2011.215 · Cited by 117
Mouse models for colorectal cancer
Heyer, J., Yang, K., Lipkin, M., Edelmann, W., & Kucherlapati, R. (1999) · Oncogene · doi:10.1038/sj.onc.1203036 · Cited by 120
A Gene for Familial Juvenile Polyposis Maps to Chromosome 18q21.1
Howe, J. R., Ringold, J. C., Summers, R. W., Mitros, F. A., Nishimura, D. Y., & Stone, E. M. (1998) · The American Journal of Human Genetics · doi:10.1086/301840 · Cited by 119
Cooperative Binding of Smad Proteins to Two Adjacent DNA Elements in the Plasminogen Activator Inhibitor-1 Promoter Mediates Transforming Growth Factor β-induced Smad-dependent Transcriptional Activation
Stroschein, S. L., Wang, W., & Luo, K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.14.9431 · Cited by 121
High-Grade Neuroendocrine Carcinoma of the Ampulla of Vater
Nassar, H., Albores‐Saavedra, J., & Klimstra, D. S. (2005) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000157974.05397.4f · Cited by 118
TGF-β and cancer
Reiß, M. (1999) · Microbes and Infection · doi:10.1016/s1286-4579(99)00251-8 · Cited by 118
Anterior pituitary hormones, stress, and immune system homeostasis
Dorshkind, K. A., & Horseman, N. D. (2001) · BioEssays · doi:10.1002/1521-1878(200103)23:3 · Cited by 157
Advances in pancreatic cancer biomarkers
Hasan, S. M., Jacob, R., Manne, U., & Paluri, R. K. (2019) · Oncology Reviews · doi:10.4081/oncol.2019.410 · Cited by 124
Genetic Alterations in Goblet Cell Carcinoids of the Vermiform Appendix and Comparison with Gastrointestinal Carcinoid Tumors
Stancu, M., Wu, T., Wallace, C., Houlihan, P., Hamilton, S. R., & Rashid, A. (2003) · Modern Pathology · doi:10.1097/01.mp.0000097362.10330.b1 · Cited by 117
Cytogenetic analysis of pancreatic carcinomas: Intratumor heterogeneity and nonrandom pattern of chromosome aberrations
Gorunova, L., Höglund, M., Andrén‐Sandberg, Å., Dawiskiba, S., Jin, Y., Mitelman, F., & Johansson, B. (1998) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199810)23:2 · Cited by 118
Distinct Oligomeric States of SMAD Proteins in the Transforming Growth Factor-β Pathway
Jayaraman, L., & Massagué, J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005799200 · Cited by 117
Oncogenic Ras Represses Transforming Growth Factor-β/Smad Signaling by Degrading Tumor Suppressor Smad4
Saha, D., Datta, P. K., & Beauchamp, R. D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100069200 · Cited by 118
Genome-wide aberrations in pancreatic adenocarcinoma
Nowak, N. J., Gaile, D. P., Conroy, J. M., McQuaid, D., Cowell, J. K., Carter, R. L., Goggins, M., Hruban, R. H., & Maitra, A. (2005) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2005.01.009 · Cited by 115
Self-citation
Conservation of dorsal-ventral patterning in arthropods and chordates
Ferguson, E. L. (1996) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(96)80063-3 · Cited by 117
TGF-β: A Balancing Act
McCartney-Francis, N. L., Frazier-Jessen, M. R., & Wahl, S. M. (1998) · International Reviews of Immunology · doi:10.3109/08830189809043009 · Cited by 117
Expression of G1-S modulators (p53, p16, p27, cyclin D1, Rb) and Smad4/Dpc4 in intrahepatic cholangiocarcinoma
Kang, Y. K., Kim, W. H., & Jang, J. J. (2002) · Human Pathology · doi:10.1053/hupa.2002.127444 · Cited by 116
Bone morphogenetic protein signaling and growth suppression in colon cancer
Beck, S. E., Jung, B. H., Fiorino, A., Gomez, J., Rosario, E. D., Cabrera, B. L., Huang, S. C., Chow, J. Y. C., & Carethers, J. M. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00482.2005 · Cited by 116
Evidence of selection for clones having genetic inactivation of the activin A type II receptor (ACVR2) gene in gastrointestinal cancers.
Hempen, P. M., Zhang, L., Bansal, R. K., Iacobuzio–Donahue, C. A., Murphy, K. M., Maitra, A., Vogelstein, B., Whitehead, R. H., Markowitz, S. D., Willson, J. K. V., et al. (2003) · PubMed · Cited by 115
Self-citation
LRP-DIT, a putative endocytic receptor gene, is frequently inactivated in non-small cell lung cancer cell lines.
Liu, C. X., Musco, S., Lisitsina, N. M., Forgacs, E., Minna, J. D., & Lisitsyn, N. A. (2000) · PubMed · Cited by 115
Expression of MAP4K4 Is Associated with Worse Prognosis in Patients with Stage II Pancreatic Ductal Adenocarcinoma
Liang, J. J., Wang, H., Rashid, A., Tan, T., Hwang, R. F., Hamilton, S. R., Abbruzzese, J. L., Evans, D. B., & Wang, H. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0381 · Cited by 115
Biology and Clinical Applications of Pancreatic Cancer Stem Cells
Abel, E. V., & Simeone, D. M. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.01.072 · Cited by 114
Smad proteins and transforming growth factor-β signaling
Schiffer, M., von Gersdorff, G., Bitzer, M., Suszták, K., & Böttinger, E. P. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.07708.x · Cited by 114
Increased smad expression and activation are associated with apoptosis in normal and malignant prostate after castration.
Brodin, G., ten Dijke, P., Funa, K., Heldin, C., & Landström, M. (1999) · PubMed · Cited by 114
Indian hedgehog signaling pathway: Expression and regulation in pancreatic cancer
Kayed, H., Kleeff, J. H., Keleg, S., Guo, J., Ketterer, K., Berberat, P. O., Giese, N. A., Esposito, I., Giese, T., Büchler, M. W., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.20194 · Cited by 113
Frequent Silencing of the Candidate Tumor Suppressor PCDH20 by Epigenetic Mechanism in Non–Small-Cell Lung Cancers
Imoto, I., Izumi, H., Yokoi, S., Hosoda, H., Shibata, T., Hosoda, F., Ohki, M., Hirohashi, S., & Inazawa, J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4437 · Cited by 113
Inactivation of SMAD4 Tumor Suppressor Gene During Gastric Carcinoma Progression
Wang, L., Kim, S.-H., Lee, J. H., Choi, Y., Kim, Y. C., Park, T. S., Hong, Y., Wu, C., & Shin, Y. K. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1467 · Cited by 113
The Drosophila Medea gene is required downstream of dpp and encodes a functional homolog of human Smad4
Hudson, J. B., Podos, S. D., Keith, K., Simpson, S. L., & Ferguson, E. L. (1998) · Development · doi:10.1242/dev.125.8.1407 · Cited by 113
TGF‐βs: their role in testicular function and Sertoli cell tight junction dynamics
Lui, W., Lee, W. M., & Cheng, C. Y. (2003) · International Journal of Andrology · doi:10.1046/j.1365-2605.2003.00410.x · Cited by 115
Transforming Growth Factor-β Signaling in Epithelial Cells
Hartsough, M. T., & Mulder, K. M. (1997) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(97)00020-x · Cited by 112
Pancreatic Intraepithelial Neoplasia Revisited and Updated
Sipos, B., Frank, S., Gress, T. M., Hahn, S. A., & Klöppel, G. (2008) · Pancreatology · doi:10.1159/000178874 · Cited by 112
Self-citation
Neurokinin-1 Receptor Expression and Its Potential Effects on Tumor Growth in Human Pancreatic Cancer
Frieß, H., Zhu, Z., Liard, V., Shi, X., Shrikhande, S. V., Wang, L., Lieb, K., Korc, M., Palma, C., Zimmermann, A., et al. (2003) · Laboratory Investigation · doi:10.1097/01.lab.0000067499.57309.f6 · Cited by 112
Perturbation of transforming growth factor (TGF)-ß1 association with latent TGF-β binding protein yields inflammation and tumors
Yoshinaga, K., Obata, H., Jurukovski, V., Mazzieri, R., Chen, Y., Zilberberg, L., Huso, D. L., Melamed, J., Prijatelj, P., Todorović, V., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805411105 · Cited by 113
Loss of Dpc4 Expression in Colonic Adenocarcinomas Correlates with the Presence of Metastatic Disease
Maitra, A., Molberg, K. H., Albores‐Saavedra, J., & Lindberg, G. M. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64625-1 · Cited by 112
Growth Inhibition by Insulin-like Growth Factor-binding Protein-3 in T47D Breast Cancer Cells Requires Transforming Growth Factor-β (TGF-β) and the Type II TGF-β Receptor
Fanayan, S., Firth, S. M., Butt, A. J., & Baxter, R. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006964200 · Cited by 112
Molecular cytogenetic analysis of non-small cell lung carcinoma by spectral karyotyping and comparative genomic hybridization
Luk, C. K., Tsao, M., Bayani, J., Shepherd, F. A., & Squire, J. A. (2001) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(00)00363-0 · Cited by 112
Transforming Growth Factor-β: A Neuroprotective Factor in Cerebral Ischemia
Dhandapani, K. M., & Brann, D. W. (2003) · Cell Biochemistry and Biophysics · doi:10.1385/cbb:39:1:13 · Cited by 113
Loss of heterozygosity as a predictor to map tumor suppressor genes in cancer: molecular basis of its occurrence
Thiagalingam, S., Foy, R. L., Cheng, K., Lee, H. J., Thiagalingam, A., & Ponte, J. F. (2002) · Current Opinion in Oncology · doi:10.1097/00001622-200201000-00012 · Cited by 111
The Drosophila gene Medea demonstrates the requirement for different classes of Smads in dpp signaling
Das, P. K., Maduzia, L. L., Wang, H., Finelli, A. L., Cho, S., Smith, M. M., & Padgett, R. W. (1998) · Development · doi:10.1242/dev.125.8.1519 · Cited by 111
Rare ductal adenocarcinoma of the pancreas in patients younger than age 40 years
Lüttges, J., Stigge, C., Pacena, M., & Klöppel, G. (2003) · Cancer · doi:10.1002/cncr.11860 · Cited by 110
Evidence for a Novel Osteosarcoma Tumor-Suppressor Gene in the Chromosome 18 Region Genetically Linked with Paget Disease of Bone
Nellissery, M. J., Padalecki, S. S., Brkanac, Z., Singer, F. R., Roodman, G. D., Unni, K. K., Leach, R. J., & Hansen, M. F. (1998) · The American Journal of Human Genetics · doi:10.1086/302019 · Cited by 110
Novel Markers of Pancreatic Adenocarcinoma in Fine-Needle Aspiration: Mesothelin and Prostate Stem Cell Antigen Labeling Increases Accuracy in Cytologically Borderline Cases
McCarthy, D. M., Maitra, A., Argani, P., Rader, A. E., Faigel, D. O., van Heek, N. T., Hruban, R. H., & Wilentz, R. E. (2003) · Applied immunohistochemistry & molecular morphology · doi:10.1097/00129039-200309000-00006 · Cited by 110
Self-citation
Jab1/CSN5, a Component of the COP9 Signalosome, Regulates Transforming Growth Factor β Signaling by Binding to Smad7 and Promoting Its Degradation
Kim, B.-C., Lee, H.-J., Park, S. H., Lee, S. R., Karpova, T., McNally, J. G., Felici, A., Lee, D. K., & Kim, S. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.6.2251-2262.2004 · Cited by 110
Guidelines for pancreaticobiliary cytology from the Papanicolaou Society of Cytopathology: A review
Pitman, M. B., & Layfield, L. J. (2014) · Cancer Cytopathology · doi:10.1002/cncy.21427 · Cited by 109
Roles of Smad3 in TGF-β Signaling During Carcinogenesis
Millet, C., & Zhang, Y. E. (2007) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v17.i4.30 · Cited by 109
Genomic Profiling Identifies GATA6 as a Candidate Oncogene Amplified in Pancreatobiliary Cancer
Kwei, K. A., Bashyam, M. D., Kao, J., Ratheesh, R., Edamakanti, C. R., Kim, Y. H., Montgomery, K. D., Giacomini, C. P., Choi, Y., Chatterjee, S., et al. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000081 · Cited by 111
Transforming growth factor β-inducible independent binding of SMAD to the Smad7 promoter
Denissova, N. G., Pouponnot, C., Long, J., He, D., & Liu, F. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.090099297 · Cited by 112
Genetic Diversity of Pancreatic Ductal Adenocarcinoma and Opportunities for Precision Medicine
Knudsen, E. S., O'Reilly, E. M., Brody, J. R., & Witkiewicz, A. K. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.08.056 · Cited by 115
Smad Transcriptional Corepressors in TGFβ Family Signaling
Wotton, D., & Massagué, J. (2001) · Current topics in microbiology and immunology · doi:10.1007/978-3-662-10595-5_8 · Cited by 107
BMP2 exposure results in decreased PTEN protein degradation and increased PTEN levels
Waite, K. A., & Eng, C. (2003) · Human Molecular Genetics · doi:10.1093/hmg/12.6.679 · Cited by 108
Plasma DNA microsatellites as tumor-specific markers and indicators of tumor progression in melanoma patients.
Fujiwara, Y., Chi, D. D., Wang, H., Keleman, P., Morton, D. L., Turner, R. R., & Hoon, D. S. �. (1999) · PubMed · Cited by 108
Determination of the frequency of the common 657Del5 Nnijmegen breakage syndrome mutation in the German population: No association with risk of breast cancer
Carlomagno, F., Chang-Claude, J. C., Dunning, A. M., & Ponder, B. A. J. (1999) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199908)25:4 · Cited by 48

Authors: Hahn, S. A., Schutte, M., Shamsul Hoque, A. T. M., Moskaluk, C. A., da Costa, L. T., Rozenblum, E., Weinstein, C. L., Fischer, A., Yeo, C. J., Hruban, R. H., & Kern, S. E.
Affiliations: Johns Hopkins University (US)
S. A. Hahn, M. Schutte, A. T. M. S. Hoque, C. A. Moskaluk, E. Rozenblum, C. L. Weinstein, A. Fischer, R. H. Hruban, Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
L. T. da Costa, Graduate Program in Human Genetics and Molecular Biology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Corresponding author: Kern, Scott E.
ORCID: Hahn, Stephan A.
Moskaluk, Christopher A.
Fischer, Aryeh
Yeo, Charles J.
Hruban, Ralph H.
Kern, Scott E.
Venue: Science
Publisher: American Association for the Advancement of Science (AAAS)
Published: 1996-01-19
Volume: 271
Issue: 5247
Pages: 350-353
ISSN: 0036-8075 (ISSN-L)
1095-9203
DOI: 10.1126/science.271.5247.350
OpenAlex: W2100522747
Cited by: 2,337
References: 25
Citations by year: 2026: 20 · 2025: 21 · 2024: 29 · 2023: 26 · 2022: 31 · 2021: 41 · 2020: 33 · 2019: 44 · 2018: 41 · 2017: 46 · 2016: 55 · 2015: 59 · 2014: 71 · 2013: 64 · 2012: 67
FWCI: 70.80
Type: journal article
Language: en
Open access: closed
Locations: Science (publishedVersion)
PubMed (publishedVersion)
Funders: National Cancer Institute (P50CA062924, CA 62924)
Topics: Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Keywords: SMAD4, tumor suppressor, pancreatic cancer, homozygous deletion, loss of heterozygosity, TGF-beta signaling, loss-of-function mutations, candidate gene identification
MeSH terms: Alleles, Amino Acid Sequence, Animals, Base Sequence, Cell Division, Chromosome Mapping, Chromosomes, Human, Pair 18, DNA-Binding Proteins, Genetic Markers, Humans, Molecular Sequence Data, Mutation, Neoplasm Transplantation, Pancreatic Neoplasms, Proteins, Transplantation, Heterologous, Tumor Cells, Cultured, Signal Transduction, Trans-Activators, Gene Expression, Genes, Tumor Suppressor, Transforming Growth Factor beta, Gene Deletion, Mice, Smad4 Protein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

DPC4 , A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks